Stay updated on Inhaled ZYESAMI Clinical Trial
Sign up to get notified when there's something new on the Inhaled ZYESAMI Clinical Trial page.

Latest updates to the Inhaled ZYESAMI Clinical Trial page
- Check2 days agoChange DetectedA new Revision: v3.5.4 was added, replacing the previous Revision: v3.5.3.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page's revision history now shows Revision: v3.5.3, replacing the previous Revision: v3.5.2. This is an administrative update to the page metadata and does not modify the study details or user-facing content.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedAdded metadata entries including the keyword 'Pathogenesis of COVID-19 from a cell biologic perspective' and sponsor-related notes ('APR Applied Pharma Research s.a.'; 'Helpful Links Provided by APR'), and updated the revision from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check38 days agoChange DetectedRemoved the 'Pathogenesis of COVID-19 from a cell biologic perspective' section and the sponsor/credit information for APR Applied Pharma Research s.a., as well as the 'Helpful Links Provided by' label from the study page.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision update: v3.5.0 replaces the previous v3.4.3.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a minor technical update with no substantive changes to the study details.SummaryDifference0.0%

Stay in the know with updates to Inhaled ZYESAMI Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled ZYESAMI Clinical Trial page.